Skip to main content

Table 1 Clinical characteristics of the juvenile idiopathic arthritis (JIA) cohort and control group

From: Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study

Characteristics

Juvenile idiopathic arthritis

Control

Total no. assessed

Values

Total no. assessed

Values

Female sex

96

68

(71)

109

77

(71)

Fulltime school or work

94

73

(78)

109

86

(79)

Age at visit, years, median (IQR)

96

22.7

(18.7–26.2)

109

23.5

(20.2–26.7)

Age at disease onset, years, median (IQR)

96

6.4

(2.7–11.7)

 

Disease duration at visit, years, median (IQR)

96

16.1

(14.2–17.1)

 

Oligoarticular JIA at onset

96

51

(53)

 

Oligoarticular JIA at visita

96

45

(47)

 

Not in remission at visitb

96

53

(55)

 

DMARDs and/or biologics at visit

96

34

(35)

 

HAQ, median (IQR)

96

0

(0.0–0.125)

 

Women: hormonal contraceptives

68

42

(62)

74

48

(65)

Women: days since LMP, median (IQR)

54

14

(6–26)

69

19

(9–39)

Alcohol consumption at day of visitc

95

0

(0)

109

2

(2)

Use of tobacco at day of visitc

93

21

(23)

106

22

(21)

Consumption of coffee/tea/cola at day of visitc

95

36

(38)

109

28

(26)

Pain or psychotropic medication at day of visitd

95

4

(4)

107

2

(2)

SF-36 PCS, mean (± SD)

96

51.1

(± 9.5)

109

55.1

(± 7.9)

SF-36 MCS, mean (± SD)

96

47.7

(± 11.6)

109

47.5

(± 9.7)

  1. Unless otherwise stated, values indicate numbers (%); no. numbers; IQR interquartile range, 1st–3rd; DMARDs disease-modifying anti-rheumatic drugs; biologics biologic drugs; HAQ Health Assessment Questionnaire, 0–3 (0 = lowest, 3 = highest); LMP last menstrual period; SD standard deviation; SF-36 Short-form 36 Health Status Questionnaire, 0–100 (< 40 poor health); PCS physical component summary; MCS mental component summary
  2. aPersistent (no. = 27) and extended (no. = 18) oligoarticular disease
  3. bNot in remission off medication for ≥ 12 months according to the definition by Wallace et al.
  4. cConsumption after 00.00 on the day of visit
  5. dPain or psychotropic medication after 00.00 on the day of visit, including JIA: ibuprofen (n = 1), methylphenidate (n = 2), and prednisolone (n = 1) and control: paracetamol (n = 1) and lisdexamfetamine (n = 1)